Age and race as prognostic factors in endometrial carcinoma

被引:19
作者
Aziz, H
Hussain, F
Edelman, S
Cirrone, J
Aral, I
Fruchter, R
Homel, P
Rotman, M
机构
[1] SUNY HLTH SCI CTR, DEPT OBSTET & GYNECOL, BROOKLYN, NY 11203 USA
[2] SUNY HLTH SCI CTR, CTR COMP SCI, BROOKLYN, NY 11203 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1996年 / 19卷 / 06期
关键词
carcinoma of the endometrium; age; race;
D O I
10.1097/00000421-199612000-00014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research was undertaken to evaluate the effects of age and race on prognosis of patients with endometrial carcinoma. A total of 279 patients with endometrial carcinoma treated at State University of New York-Health Science Center and Kings County Hospital Brooklyn, New York from 1975 to 1990 were retrospectively analyzed. Patients were arbitrarily divided into young and old groups (less than or equal to 60 years or >60 yeats old, respectively). The distribution of grade, clinical stage, and extent of myometrial invasion by age was determined for the entire group and for black and white patients, respectively. Young and old patients were stratified by clinical stage, grade, and extent of myometrial invasion. The corrected median survival of young and old patients by race was evaluated by Kaplan Meier's method of analysis. Older patients in general had higher clinical stage, higher grade, and greater depth of myometrial invasion than younger patients. Also, black patients had higher clinical stage, higher grade, and greater depth of myometrial invasion than white patients. Older black patients had the least favorable distribution of prognostic factors. Overall younger patients had a median survival of 200 months compared to 90 months for older patients (p = 0.0085). The overall corrected median survival for whites was 232 months compared to 108 months for blacks (p = 0.0001). The median survival of older black patients was worst at 40 months, compared to 155 months for older white patients (p = 0.0005). Age is a very important prognostic factor in endometrial carcinoma for both blacks and whites, and it appears to be more pronounced in older black patients.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 25 条
[11]  
LARSON DM, 1987, CANCER, V60, P1358, DOI 10.1002/1097-0142(19870915)60:6<1358::AID-CNCR2820600633>3.0.CO
[12]  
2-O
[13]  
LINDAHL B, 1992, ANTICANCER RES, V12, P409
[14]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[15]   THE EFFECT OF ESTROGEN-RECEPTOR STATUS ON SURVIVAL IN PATIENTS WITH ENDOMETRIAL CANCER [J].
MARTIN, JD ;
HAHNEL, R ;
MCCARTNEY, AJ ;
WOODINGS, TL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 147 (03) :322-324
[16]   PROLIFERATING CELL NUCLEAR ANTIGEN IN ENDOMETRIAL ADENOCARCINOMAS OF ENDOMETRIOID TYPE CORRELATED WITH HISTOLOGIC GRADE, STAGE, PREVIOUS HORMONAL TREATMENT, AND SURVIVAL [J].
NIELSEN, AL ;
NYHOLM, HCJ .
HUMAN PATHOLOGY, 1993, 24 (09) :1003-1007
[17]  
PREMPREE T, 1983, CANCER, V51, P1764, DOI 10.1002/1097-0142(19830501)51:9<1764::AID-CNCR2820510934>3.0.CO
[18]  
2-8
[19]  
PRESSOR I, 1984, UPSALA J MED SCI, V89, P159
[20]  
RECHT A, 1986, International Journal of Radiation Oncology, Biology, Physics, V12, P93